ESR1 and breast cancer: A number of studies have reported that genes involved in PPP are dysregulated in HR+ breast cancer and that altered expression of these genes by estrogen and/or estrogen-dependent signaling can directly or indirectly contribute to ER+ breast cancer tumorigenesis and progression [74,76].